Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Stimuli-responsive cargo release refers to the engineering of drug delivery systems that release therapeutic agents in response to specific physiological or externally applied stimuli, such as pH changes, enzymatic activity, redox potential, temperature, light, or magnetic fields. These smart carriers aim to improve the spatial and temporal control of drug delivery, increasing efficacy and reducing side effects, particularly in applications such as cancer therapy. The strategy is implemented using a variety of materials (nanoparticles, polymers, liposomes, dendrimers), and the trigger for release is often chosen to exploit unique features of diseased tissue (e.g., acidic tumor microenvironment, overexpressed enzymes). While this approach is promising and widely researched, it is not a molecular drug target itself, but a property engineered into delivery vehicles.
Release of encapsulated or conjugated therapeutic agents upon sensing a specific stimulus (e.g. pH, enzyme, redox, temperature, light, magnetic field)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Stimuli-responsive cargo release.